| 000 | 01460 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513103940.0 | ||
| 264 | 0 | _c19970224 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a0149-5992 | ||
| 024 | 7 |
_a10.2337/diacare.19.11.1194 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRosenstock, J | |
| 245 | 0 | 0 |
_aGlimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group. _h[electronic resource] |
| 260 |
_bDiabetes care _cNov 1996 |
||
| 300 |
_a1194-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aC-Peptide _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPostprandial Period |
| 650 | 0 | 4 |
_aSulfonylurea Compounds _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSamols, E | |
| 700 | 1 | _aMuchmore, D B | |
| 700 | 1 | _aSchneider, J | |
| 773 | 0 |
_tDiabetes care _gvol. 19 _gno. 11 _gp. 1194-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diacare.19.11.1194 _zAvailable from publisher's website |
| 999 |
_c8900888 _d8900888 |
||